Institut Bordet - Retour à la page d'accueil
en
I want to donate to research

Francesco Sclafani

Department : Medical oncology
 
francesco.sclafani [at] bordet.be

Publications

Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer.

Authors : Bregni G, Vandeputte C, Pretta A, Senti C, Trevisi E, Acedo Reina E, Kehagias P, Liberale G, Moretti L, Bali MA, Demetter P, Flamen P, Carrasco J, DHondt L, Geboes K, Gokburun Y, Peeters M, Van den Eynde M, Van Laethem JL, Vergauwe P, Chapot CA, Buyse M, Deleporte A, Hendlisz A, Sclafani F
Year : 2021
Journal : Acta Oncol

Leukemia Inhibitory Factor: A Potential Biomarker and Therapeutic Target in Pancreatic Cancer.

Authors : Wrona E, Potemski P, Sclafani F, Borowiec M
Year : 2021
Journal : Arch Immunol Ther Exp (Warsz)

Anal squamous cell carcinoma: standards of care, new data and ongoing clinical trials.

Authors : Giunta EF, Bregni G, Hendlisz A, Sclafani F
Year : 2021
Journal : Curr Opin Oncol

Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials.

Authors : Giunta EF, Bregni G, Pretta A, Deleporte A, Liberale G, Bali AM, Moretti L, Troiani T, Ciardiello F, Hendlisz A, Sclafani F
Year : 2021
Journal : Cancer Treat Rev

Intratumoral Transcriptome Heterogeneity Is Associated With Patient Prognosis and Sidedness in Patients With Colorectal Cancer Treated With Anti-EGFR Therapy From the CO.20 Trial.

Authors : Fontana E, Nyamundanda G, Cunningham D, Tu D, Cheang MCU, Jonker DJ, Siu LL, Sclafani F, Eason K, Ragulan C, Bali MA, Hulkki-Wilson S, Loree JM, Waring PM, Giordano M, Lawrence P, Rodrigues DN, Begum R, Shapiro JD, Price TJ, Cremolini C, Starling N, Pietrantonio F, Trusolino L, OCallaghan CJ, Sadanandam A
Year : 2020
Journal : JCO Precis Oncol

More publications »

Follow us!

Youtube

Exclusive images of the new Jules Bordet Institute!

The new Institut Jules Bordet, a building for the practice of medical excellence now and in the future. Meeting at the end of November 2021 on the ULB campus in Anderlecht.